Longevica
1 known investors
Focused on longevity technologies; Foundation sold its equity interest to Rostock International, Ltd.
Investors · 1
Competitors · 4
by search overlap
Longeveron4 shared keywordsLongeveron is a clinical-stage biotechnology company developing allogeneic cellular therapies for life-threatening conditions affecting children and the elderly. Its investigational candidate is being evaluated for indications including Hypoplastic Left Heart Syndrome, Pediatric Dilated Cardiomyopathy, Alzheimer's Disease, and age-related frailty.
Longevity Fund3 shared keywordsThe Longevity Fund is a venture capital firm founded in 2011 to back founder-led biotech companies developing drugs for longevity and age-related diseases. It has since relaunched as a new fund under the name age1.
Longevity Medical Institute3 shared keywordsLongevity Medical Institute provides regenerative medicine, anti-aging therapies, and diagnostics for patients seeking personalized care. The clinic combines stem cell therapy, hormone optimization, aesthetic medicine, and advanced diagnostics with specialists across multiple disciplines to address age-related health conditions.
Healthy Longevity Clinic3 shared keywordsA clinic offering personalized longevity medicine programs designed to extend healthspan through scientifically-proven interventions, combining advanced diagnostics and therapies sourced from cutting-edge research. The clinic serves individuals seeking to optimize their health and quality of life across all ages through comprehensive, systematic, and long-term personalized health protocols.
Companies competing with Longevica for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Longevica do?
- Focused on longevity technologies; Foundation sold its equity interest to Rostock International, Ltd.
- Who are Longevica's investors?
- Longevica's investors include Foundation Venture Capital Group, LLC.